Piracetam for acute ischaemic stroke

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2006, Pages

  Ricci, Stefano ^a   Celani, M G ^b   Cantisani, A T ^b   Righetti, E ^b  

^a USL 2   (Italy)

^b NONE

Author keywords

Acute disease; Brain ischemia drug therapy; mortality ; Cerebrovascular accident *drug therapy; mortality ; Humans; Neuroprotective agents adverse effects; *therapeutic use ; Piracetam adverse effects; *therapeutic use

Indexed keywords

PIRACETAM; PLACEBO;

ACUTE DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; NEUROPROTECTION; REVIEW;

EID: 42749104461     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000419.pub2     Document Type: Review

References (24)

1. Ming A, Fritz V, Winterton R, Esser J, Hinton S. Piracetam versus placebo in first, acute, non-haemorrhagic, carotid territory stroke: a double-blind pilot study. Symposium Piracetam, Athens, Greece, 29 April 1990 139-51.
2. De Deyn P, De Reuck J, Deberdt W, Vlietnick R, Orgogozo J, for members of the Piracetam in Acute Stroke Study (PASS) Group. Treatment of acute ischemic stroke with piracetam. Stroke 1997;28:2347-52.
3. Platt D, Horn J, Summa J, Shimitt-Ruth R, Kaunntz J, Kronert E. On the efficacy of piracetam in geriatric patients with acute cerebral ischemia: a clinical controlled double-blind study. Archives of Gerontology and Geriatrics 1993;16:149-64.
4. Burd GS, Gusev EI, Skvortsova VI, Konstantinova MV, Bolotov DA, Vanichkyn AV. The use of piracetam (nootropil) in acute hemispheric ischemic stroke (HIS). European Journal of Neurology 1997;4(Suppl 1):S51.
5. Creytens G. Some new approaches in the treatment of cerebral pathology. Acta Therapeutica 1980;6:33-53.
6. Garcia Pastor A, Diaz Otero F, Gill Lunez AC, Villanueva Osorio JA. Tolerability and efficacy of the combination of piracetam and citicoline in acute ischaemic stroke. A randomised comparative open study. Stroke 2004;35(6):e286.
7. Gusev EI, Burd GS, Jekht AB, Skwortsova VI, Selikhova MV, Pavlow NA, et al. The metabolic therapy of acute stroke: the use of nootropil. Zhurnal Nevrologii I Psickhiatrii imenuii S.S. Korasakowa 1997;97(10):24-8.
8. Herrshaft H. The effectiveness of piracetamin acute cerebral ischemia in man. Medizinische Klinik 1988;83:667-77.
9. Karoutas G. A randomised, double blind, placebo controlled study of piracetam in patients with acute ischaemic cerebral infarct in carotid territory. Symposium Piracetam. 1990:135-8.
10. Kartin P, Povse M, Skondia V. Clinical study of piracetam in patients with subacute cerebrovascular accidents. Acta Therapeutica 1979;5:235-43.
11. Kozubski W. Comparison of piracetam vs Dextran 40 in ischemic stroke in elderly patients. European Journal of Neurology 1995;2(Suppl 2):27.
12. Kozubski W. Piracetam vs dextran 40 in acute ischaemic stroke in elderly patients [Porownanie skutecznosci piracetamu i dekstranu 40 tys. u chorych w podeszlym wieku z niedokrwiennym udarem mozgu]. Wiadomosci Lekarskie 1998;51(7-8):321-5.
13. Kozubski W. Piracetam vs Dextran 40 in acute ischemic stroke in elderly patients - a single blind study. Journal of Neurology 1997;244(Suppl 3):S55 (Abst. P251).
14. Meng QL, Geng JG. Ganglioside GM1 in treating acute cerebral infarction. Chinese Journal of New Drugs and Clinical Remedies 2003;22(1):19- 21.
15. Orgogozo JM, De Reuck J, Van Vleymen B, for the PASS II Group. Piracetam Acute Stroke Study II (PASS II). Cerebrovascular Disease 1998;8 (Suppl 4):84.
16. Piradov M, Susline Z, Lebedeva N, Altunine M, Shchunkin J. Piracetam in acute ischaemic stroke. Cerebrovascular Diseases 1992;2:235.
17. Tunali F, Ozalp K, Erdogan N, Ozge A, Misirli A, Erenoglu N. The value of piracetam on acute ischemic stroke. European Journal of Neurology 1997;4 (Suppl 1):152.
18. Zhang L-L, Li H-Y, Li Y-Z. Citicoline capsules vs piracetam tablets in treatment of cerebral infarction. Chinese Journal of New Drugs and Clinical Remedies 2002;21:202-4.
19. Giurgea C, Mouravieff-Lesuisse F, Leemans R. [Correlations electropharmacologiques au cours de l'anoxic oxyprive chez le lapin en respiration libre ou artificielle]. Revue Neurologique (Paris) 1970;122:484-6.
20. Greener J, Enderby P, Whurr R. Pharmacological treatment for aphasia following stroke. In: The Cochrane Database of Systematic Reviews, 4, 2001.
21. Herrschft H. The effect of piracetam on global and regional cerebral blood flow in acute cerebral ischemia of man. Medizinische Klinik 1978;73:195-202.
22. Moriau M, Crasborn L, Lavenne-Pardonge E. Platelet antiaggregant and rheological properties of piracetam: a pharmacodynamic study in normal subjects. Arzneimittel-Forschung 1993;43:110-8.
23. Noble S, Benfield P. Piracetam: a review of its potential as a rehabilitative treatment after stroke. CNS Drugs 1996;5(6):1-12.
24. Schaffler K, Klausnitzer W. Randomized placebo-controlled double-blind cross-over study on antihyoxidotic effects of piracetam using psychophysiological measures in healthy volunteers. Arzneimittel-Forschung 1988;38:288-91.